Sovereign backed Bioscript makes third acquisition in just over 12 months Read more

  • Status: Realised
  • Date: 2010 to 2019
  • Sector:
    • Healthcare & Pharma Services

Back to Investments

Christchurch Group

Christchurch Group is one of the UK's leading specialist multidisciplinary neurological rehabilitation providers, operating at the leading edge for neurological rehabilitation.

Investment Background

Founded in 1997, Christchurch operates from units in a community setting, providing rehabilitation and high-acuity care to adults with neurological and spinal conditions resulting from injury, illness or disease. In 2010, the founders decided to retire and wanted a buyer that would build upon the high quality offering they had created. They chose Sovereign, and the Christchurch Group was established.

Value Creation

  • Extended geographic reach through the addition of six new locations
  • Expanded the Group's service offering
  • Increased the level of clinical expertise and outcomes for patients

The story so far

At the time of Sovereign's original investment, the Group operated from adjacent facilities in Northampton in a community setting. With Sovereign's support Christchurch:

  • more than trebled in size as a result of: acquiring Birmingham-based Hunters Moor; opened full-service neuro-rehabiliation units in York, Harwell, and Lincoln, and opened a new step-down community facility in Bedford.
  • developed a transitional living space in Northampton, extending the care pathway.
  • expanded its services to include neurobehavioural rehabilitation and specialist complex nursing including spinal injury rehabilitation, ventilated care and the management of progressive neurological conditions.

At exit, Christchurch Group was home to the largest multi-disciplinary team in the UK, offering an award-winning specialist neurological rehabilitation capability, providing life-changing, evidence-based outcomes.

Back to Investments

Christchurch Group Awards

Health Investor Awards Winner 2018

Health Investor Awards Finalist 2017

Health Investor Awards Finalist 2015